BHCHX Mutual Fund

NAV$22.10

Fund Essentials - as of Mar 31, 2026

Net Assets
-
Expense Ratio
0.85%
Dividend Yield (Current)
-
Holdings
41
Inception Date
Apr 30, 2018
Fund Family
Baron Funds
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Unspecified

Performance

YTD+3.90%
1 Year+24.19%
3 Year+5.68%
5 Year+1.56%

Asset Allocation

Stocks: 100.00%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co9.95%
AZN:LNAstraZeneca PLC5.09%
JNJJohnson & Johnson4.58%
TMOThermo Fisher4.25%
MTDMettler-Toledo International Inc.3.99%
Top 10 Concentration: 43.86%Report Date: Mar 31, 2026
Download all 41 holdings for BHCHX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Unspecified
Latest Distribution
$0.22
-

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

BHCHX Mutual Fund Overview

BHCHX Mutual Fund (Baron Health Care Fund Institutional Shares) is managed by Baron Funds. BHCHX expense ratio is 0.85%, holding 41 positions across sectors including Health Care, Unknown, Real Estate. Inception date: 2018-04-30.

BHCHX performance shows a YTD return of 3.90%. The 1-year return is 24.19% and the 5-year return is 1.56%.

BHCHX top holdings include Eli Lilly & Co (9.9%), AstraZeneca PLC (5.1%), Johnson & Johnson (4.6%), Thermo Fisher (4.3%), Mettler-Toledo International Inc. (4.0%). View all BHCHX holdings, sector breakdown, or dividend history.

BHCHX can be compared against other funds using the overlap calculator or side-by-side comparison tool. BHCHX alternatives are available via the screener, along with tax-loss harvesting opportunities.